You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
申聯生物(688098.SH)與中海生物等共設聚英動物疾病防治泰州公司
格隆匯 07-26 15:54

格隆匯 7 月 26日丨申聯生物(688098.SH)公佈,公司與關聯法人北京中海生物科技有限公司(“中海生物”)及其他非關聯方共同投資“聚英動物疾病防治泰州有限公司”(暫定名,以最終登記註冊名稱為準,“合資公司”),公司出資1600萬元,佔合資公司註冊資本的16%其中公司首期出資人民幣160萬元

公司與相關合作方共同設立合資公司,從事獸用生物製品和獸藥的研製,與公司主業以及發展戰略一致公司在獸用生物製品研究領域具有豐富經驗的同行業公司進行深度合作能夠充分發揮各方在人才、技術、毒株、實驗室條件等各方面的優勢,實現資源共享和合作共贏,有利於提高資源利用效率,加快研發進度,為本行業提供更優質的產品和服務通過本次合作,有利於促進公司豐富產品結構,增強研發及技術創新能力,提升公司綜合實力及核心競爭力

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account